Clinical trial
Valacyclovir+Temovate Gel for the Treatment of Herpes Labialis
NCT00297011 · University of Utah, Other · Completed
Key facts
| NCT number | NCT00297011 |
|---|---|
| Title | Valacyclovir+Temovate Gel for the Treatment of Herpes Labialis |
| Official title | Valacyclovir+Temovate Gel for the Episodic Treatment of Herpes Labialis: A Patient-Initiated Double-Blind, Placebo-Controlled Study, Randomized Study. |
| Lead sponsor | University of Utah, Other |
| Collaborators | GlaxoSmithKline Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Herpes Labialis |
| Intervention type | Drug |
| Interventions | valacyclovir+clobetasol gel |
| Enrollment | 300 |
| Start date | Sep 1, 2004 |
| Primary completion | Mar 1, 2007 |
| Completion | Jan 1, 2008 |
| First posted | Feb 27, 2006 |
| Last update posted | May 6, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: